共 154 条
[1]
Murai H(2011)Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey J Neurol Sci 305 97-102
[2]
Yamashita N(2001)Therapeutic options in ocular myasthenia gravis Neuromuscul Disord 11 208-216
[3]
Watanabe M(2018)Generalization after ocular onset in myasthenia gravis: a case series in Germany J Neurol 265 2773-2782
[4]
Nomura Y(2008)Medical treatment options for ocular myasthenia gravis Curr Opin Ophthalmol 19 468-478
[5]
Motomura M(1986)Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity Lancet 1 116-119
[6]
Yoshikawa H(1994)Myasthenia gravis N Engl J Med 330 1797-1810
[7]
Evoli A(2001)Myasthenia gravis: diagnostic and management dilemmas Curr Opin Neurol 14 583-589
[8]
Batocchi AP(2001)Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies Nat Med 7 365-368
[9]
Minisci C(2019)Update on ocular myasthenia gravis Semin Neurol 39 749-760
[10]
Di Schino C(2011)Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response J Clin Neuromuscul Dis 13 46-52